Abstract
A new, rapid and simple procedure based on dispersive liquid-liquid microextraction (DLLME) of the Cr(VI) chelate with ammonium pyrrolidine dithiocarbamate (APDC) and subsequent ICP-MS analysis of the extracts by using dried-droplet laser ablation (LA) sample introduction was developed for the determination of ultratrace amounts of Cr(VI). DLLME was performed using 1 mL of methanol containing 50 μL of CCl4 as extraction mixture. Several factors influencing the DLLME performance of Cr(VI), such as sample pH, concentration of APDC and effect of potential interferents were established. Dried microdroplets (7 μL) of the obtained extracts were ablated from a polystyrene substrate and quantitated by ICP-MS. External calibration was used in combination with platinum (195Pt) as an internal standard. No matrix-matched standards are required to perform quantitative analysis. Proposed methodology yields sufficiently low detection limits (0.11 and 0.31 μg L-1 for 52Cr and 53Cr, respectively) with precision between 4 and 8%. The method was applied to determine Cr(VI) in tap and river samples. The spike recoveries showed acceptable performance of the method, with all of the recoveries within 7% of the nominal spike values.
Keywords: Dispersive liquid-liquid microextraction, Cr(VI), Dried-droplet laser ablation, ICP-MS, Water analysis.
Current Analytical Chemistry
Title:Determination of Cr(VI) by Dispersive Liquid-Liquid Microextraction and Dried-Droplet Laser Ablation ICP-MS
Volume: 6 Issue: 4
Author(s): Ina Razmislevicien, Audrius Padarauskas, Birut Pranaityt and Evaldas Naujalis
Affiliation:
Keywords: Dispersive liquid-liquid microextraction, Cr(VI), Dried-droplet laser ablation, ICP-MS, Water analysis.
Abstract: A new, rapid and simple procedure based on dispersive liquid-liquid microextraction (DLLME) of the Cr(VI) chelate with ammonium pyrrolidine dithiocarbamate (APDC) and subsequent ICP-MS analysis of the extracts by using dried-droplet laser ablation (LA) sample introduction was developed for the determination of ultratrace amounts of Cr(VI). DLLME was performed using 1 mL of methanol containing 50 μL of CCl4 as extraction mixture. Several factors influencing the DLLME performance of Cr(VI), such as sample pH, concentration of APDC and effect of potential interferents were established. Dried microdroplets (7 μL) of the obtained extracts were ablated from a polystyrene substrate and quantitated by ICP-MS. External calibration was used in combination with platinum (195Pt) as an internal standard. No matrix-matched standards are required to perform quantitative analysis. Proposed methodology yields sufficiently low detection limits (0.11 and 0.31 μg L-1 for 52Cr and 53Cr, respectively) with precision between 4 and 8%. The method was applied to determine Cr(VI) in tap and river samples. The spike recoveries showed acceptable performance of the method, with all of the recoveries within 7% of the nominal spike values.
Export Options
About this article
Cite this article as:
Razmislevicien Ina, Padarauskas Audrius, Pranaityt Birut and Naujalis Evaldas, Determination of Cr(VI) by Dispersive Liquid-Liquid Microextraction and Dried-Droplet Laser Ablation ICP-MS, Current Analytical Chemistry 2010; 6 (4) . https://dx.doi.org/10.2174/1573411011006040310
DOI https://dx.doi.org/10.2174/1573411011006040310 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Fibroblast Growth Factor Receptor Signaling in Cancer Biology and Treatment
Current Signal Transduction Therapy Mast Cells and Inflammatory Heart Disease: Potential Drug Targets
Cardiovascular & Hematological Disorders-Drug Targets Molecular Modelling and QSAR of Reversible Acetylcholines-terase Inhibitors
Current Medicinal Chemistry Comparison of P450 Enzymes Between Cynomolgus Monkeys and Humans: P450 Identities, Protein Contents, Kinetic Parameters, and Potential for Inhibitory Profiles
Current Drug Metabolism Therapeutic Utilities of Pediatric Cardiac Catheterization
Current Cardiology Reviews Late Life Depression: A Diagnostic and Pharmacological Review
Current Psychopharmacology Commentary: Research Highlights: IKKβ Mediates Aβ-Triggered Microglial Inflammation and Neuronal Death During Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets Obesity Pharmacotherapy: Current Perspectives and Future Directions
Current Cardiology Reviews Nitric Oxide in Migraine
CNS & Neurological Disorders - Drug Targets Natural Products as Promising Drug Candidates for the Treatment of Alzheimer’s Disease: Molecular Mechanism Aspect
Current Neuropharmacology Impaired Spatial Learning and Unaltered Neurogenesis in a Transgenic Model of Alzheimers Disease After Oral Aluminum Exposure
Current Alzheimer Research Trizbenzim, Cu-Trizbenzim and Zn-Trizbenzim as G-Quadruplex Inducing and Stabilizing Compounds on Human Telomeric Sequence and their Anticancer Properties
Anti-Cancer Agents in Medicinal Chemistry Meet Our Editorial Board Member
Current Protein & Peptide Science GABAA Receptor Channel Pharmacology
Current Pharmaceutical Design Environmental (Lifestyle) Risk Factors for LADA
Current Diabetes Reviews Update on the Development of microRNA and siRNA Molecules as Regulators of Cell Physiology
Recent Patents on DNA & Gene Sequences EDITORIAL (Thematic Issue: New Targets of Medical Treatment in Psychiatric Disorders)
Current Neuropharmacology Neurodegenerative Diseases Associated with Mitochondrial DNA Mutations
Current Pharmaceutical Design Noradrenergic Regulation of Hippocampus-Dependent Memory
Central Nervous System Agents in Medicinal Chemistry Mass Spectrometric Analysis of L-carnitine and its Esters: Potential Biomarkers of Disturbances in Carnitine Homeostasis
Current Molecular Medicine